Sign inJoin waitlistJoin the waitlist

Jeanna Walsh

Physician · New Hampshire Oncology-Hematology Pa

Credentials: · · · ·

History

New Hampshire Oncology-Hematology Pa · Dana-Farber Cancer Institute
Present

Hematology and Medical Oncology
Strong Memorial Hospital
2004–2007
Strong West
2001–2004
State University of New York Upstate Medical University
1997–2001

Research

Lipopolysaccharide binding protein potentiates airway reactivity in a murine model of allergic asthma
The Journal of Immunology · 2001 · 25 citations
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)
JCO Oncology Practice · 2025 · 14 citations
Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical Trial
JAMA Oncology · 2025 · 8 citations

Meredith Faggen
7 papers
Natalie Sinclair
4 papers
SS
Sarah Sinclair
4 papers
Michael Constantine
3 papers
Sara Tolaney
3 papers
Erica Mayer
2 papers
Nadine Tung
2 papers
Nancy Lin
2 papers
Rachel Freedman
2 papers
Steven Lo
2 papers
Wendy Chen
2 papers
Adrienne Waks
1 paper

Clinical trials

The Young Women's Breast Cancer Study
Principal investigator · Active not recruiting
Dana-Farber Cancer Institute
2006–2035
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Site PI · Recruiting · Phase 3
American Society of Clinical Oncology
2024–2028
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2039
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2033